US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

ATAI Life Sciences B.V.*

2.31

-0.0100-0.43%

Post-market: 2.30-0.0100-0.43%19:32 EDT

Volume:1.67M

Turnover:3.78M

Market Cap:462.78M

PE:-2.48

High:2.33

Open:2.26

Low:2.18

Close:2.32

Loading ...

Overview Company News Filings

ATAI Life Sciences NV Files Initial Statement of Beneficial Ownership for Director John Francis Hoffman

ATAI Life Sciences Approves Key Governance Changes

ATAI Life Sciences NV Conducted Annual Shareholders Meeting

TD Cowen Reaffirms Their Buy Rating on ATAI Life Sciences (ATAI)

ATAI Life Sciences: Promising Clinical Data and Strategic Investments Drive Buy Rating

Atai Life Sciences Reports Positive Phase 2a Results for Treatment-Resistant Depression Drug

MT Newswires Live

ATAI Life Sciences Price Target Maintained With a $10.00/Share by HC Wainwright & Co.

Atai Life Sciences announces data from Part 2 of Phase 2a study of BPL-003

atai Life Sciences Announces Positive Topline Data from Part 2 of Beckley Psytech’s Phase 2a Study of BPL-003 in Combination with SSRIs for Treatment-Resistant Depression

ATAI Life Sciences: Positioned for Leadership in Scalable Psychedelic Psychiatry with Strong Financial Foundation and Promising Clinical Milestones

ATAI Life Sciences: Strong Buy Rating Backed by Promising Trials and Robust Financial Health

ATAI Life Sciences: Buy Rating Backed by Promising Pipeline and Strong Cash Position Amid Upcoming Catalysts

Atai Life Sciences Reports First Quarter 2025 Financial Results

ATAI Life Sciences Q1 EPS $(0.15) Beats $(0.18) Estimate, Sales $1.55M

ATAI Life Sciences NV reports results for the quarter ended March 31 - Earnings Summary

ATAI Life Sciences Reports Q1 2025 Net Loss of $26.4M, Down from $26.7M in Q1 2024, as G&A Expenses Decrease

Press Release: atai Life Sciences Reports First Quarter 2025 Financial Results and Recent Corporate Updates

Atai Life Sciences Announces First Patient Dosed In Phase 2 Study Of Emp-01 For The Treatment Of Social Anxiety Disorder

ATAI Life Sciences NV expected to post a loss of 18 cents a share - Earnings Preview

H.C. Wainwright Remains a Buy on ATAI Life Sciences (ATAI)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ATAI/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ATAI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ATAI\",,,,,undefined,":{"symbol":"ATAI","market":"US","secType":"STK","nameCN":"ATAI Life Sciences B.V.*","latestPrice":2.31,"timestamp":1748635200000,"preClose":2.32,"halted":0,"volume":1666878,"hourTrading":{"tag":"盘后","latestPrice":2.3,"preClose":2.31,"latestTime":"19:32 EDT","volume":232486,"amount":537405.3846572001,"timestamp":1748647964597},"delay":0,"floatShares":155000000,"shares":200337609,"eps":-0.931999,"marketStatus":"Post-Mkt","change":-0.01,"latestTime":"05-30 19:37:12 EDT","open":2.26,"high":2.3299,"low":2.18,"amount":3779965.2388248,"amplitude":0.064612,"askPrice":2.43,"askSize":500,"bidPrice":2.21,"bidSize":257,"shortable":3,"etf":0,"ttmEps":-0.931999,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1748649600000},"marketStatusCode":4,"adr":1,"adrRate":2,"listingDate":1623988800000,"exchange":"NASDAQ","adjPreClose":2.32,"dividendRate":0.000433,"preHourTrading":{"tag":"盘前","latestPrice":2.3,"preClose":2.32,"latestTime":"09:28 EDT","volume":16292,"amount":37058.3436448,"timestamp":1748611682809},"postHourTrading":{"tag":"盘后","latestPrice":2.3,"preClose":2.31,"latestTime":"19:32 EDT","volume":232486,"amount":537405.3846572001,"timestamp":1748647964597},"volumeRatio":0.684914,"impliedVol":1.1714,"impliedVolPercentile":0.52},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ATAI\",,,,,undefined,":{"symbol":"ATAI","floatShares":155000000,"roa":"-26.04%","roe":"-79.43%","lyrEps":-0.931999,"volumeRatio":0.684914,"shares":200337609,"dividePrice":0.001,"high":2.3299,"amplitude":0.064612,"preClose":2.32,"low":2.18,"week52Low":1.03,"pbRate":"3.04","psRate":"248.41","week52High":2.565,"institutionHeld":0,"latestPrice":2.31,"committee":-0.321004,"eps":-0.931999,"divideRate":0.000433,"volume":1666878,"delay":0,"ttmEps":-0.931999,"open":2.26,"prevYearClose":1.33,"prevWeekClose":2.06,"prevMonthClose":1.5,"prevQuarterClose":1.36,"fiveDayClose":2.02,"twentyDayClose":1.47,"sixtyDayClose":1.61},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ATAI\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2537540901","title":"ATAI Life Sciences NV Files Initial Statement of Beneficial Ownership for Director John Francis Hoffman","url":"https://stock-news.laohu8.com/highlight/detail?id=2537540901","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537540901?lang=en_us&edition=fundamental","pubTime":"2025-05-24 04:16","pubTimestamp":1748031397,"startTime":"0","endTime":"0","summary":"ATAI Life Sciences NV has filed an initial statement of beneficial ownership with the United States Securities and Exchange Commission. The filing mentions John Francis Hoffman as the beneficial owner, who holds the role of Director. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ATAI Life Sciences NV published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 23, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250523:nNDL52GgmV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4539","ATAI"],"gpt_icon":0},{"id":"2537951778","title":"ATAI Life Sciences Approves Key Governance Changes","url":"https://stock-news.laohu8.com/highlight/detail?id=2537951778","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537951778?lang=en_us&edition=fundamental","pubTime":"2025-05-22 04:55","pubTimestamp":1747860944,"startTime":"0","endTime":"0","summary":"ATAI Life Sciences ( ($ATAI) ) has provided an announcement. On May 15, 2025, atai Life Sciences N.V. held its annual general meeting of shareholde...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/atai-life-sciences-approves-key-governance-changes?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/atai-life-sciences-approves-key-governance-changes?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4007","ATAI"],"gpt_icon":0},{"id":"2537613959","title":"ATAI Life Sciences NV Conducted Annual Shareholders Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2537613959","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537613959?lang=en_us&edition=fundamental","pubTime":"2025-05-22 04:16","pubTimestamp":1747858593,"startTime":"0","endTime":"0","summary":"ATAI Life Sciences NV held its annual general meeting of shareholders on May 15, 2025. The shareholders approved the adoption of the Dutch statutory annual accounts for fiscal year 2024. Deloitte & Touche LLP and Deloitte Accountants B.V. were appointed as the external auditor for fiscal year 2025. Members of the supervisory and management boards were released from liability for the exercise of their duties during fiscal year 2024. The authorization of the management board to issue shares and grant rights to subscribe for shares was extended. The management board's authorization to limit and exclude pre-emption rights was also extended. Additionally, the authorization of the management board to acquire shares or depositary receipts for such shares in the company's capital was extended.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250521:nNDL4CVYL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4007","ATAI"],"gpt_icon":0},{"id":"2537098705","title":"TD Cowen Reaffirms Their Buy Rating on ATAI Life Sciences (ATAI)","url":"https://stock-news.laohu8.com/highlight/detail?id=2537098705","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537098705?lang=en_us&edition=fundamental","pubTime":"2025-05-21 19:35","pubTimestamp":1747827350,"startTime":"0","endTime":"0","summary":"In a report released today, Ritu Baral from TD Cowen maintained a Buy rating on ATAI Life Sciences (ATAI – Research Report). The company’s shares c...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/td-cowen-reaffirms-their-buy-rating-on-atai-life-sciences-atai-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/td-cowen-reaffirms-their-buy-rating-on-atai-life-sciences-atai-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TD","COWN","ATAI"],"gpt_icon":0},{"id":"2537449986","title":"ATAI Life Sciences: Promising Clinical Data and Strategic Investments Drive Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2537449986","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537449986?lang=en_us&edition=fundamental","pubTime":"2025-05-21 00:15","pubTimestamp":1747757711,"startTime":"0","endTime":"0","summary":"Analyst Andrew Tsai of Jefferies maintained a Buy rating on ATAI Life Sciences (ATAI – Research Report), with a price target of $5.00. Andrew Tsai’...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/atai-life-sciences-promising-clinical-data-and-strategic-investments-drive-buy-rating?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/atai-life-sciences-promising-clinical-data-and-strategic-investments-drive-buy-rating?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ATAI"],"gpt_icon":0},{"id":"2536261263","title":"Atai Life Sciences Reports Positive Phase 2a Results for Treatment-Resistant Depression Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2536261263","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536261263?lang=en_us&edition=fundamental","pubTime":"2025-05-20 20:04","pubTimestamp":1747742679,"startTime":"0","endTime":"0","summary":"Atai Life Sciences  said Tuesday that topline data from a phase 2a trial showed that a single dose of its drug BPL-003, when given to patients who were also taking defined selective serotonin reuptake inhibitors, produced antidepressive effects of up to three months.The drug was well-tolerated with no serious adverse events, and an average in-clinic treatment time following dosing of less than two hours, the company said.The 12-patient study showed average MADRS score reductions of 18 to 19 points up to three months post-treatment, supporting prior monotherapy findings, Atai said.Atai shares were 3.8% lower in recent premarket trading.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4539","ATAI","BK4007"],"gpt_icon":0},{"id":"2536261255","title":"ATAI Life Sciences Price Target Maintained With a $10.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2536261255","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536261255?lang=en_us&edition=fundamental","pubTime":"2025-05-20 20:01","pubTimestamp":1747742460,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ATAI/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 20, 2025 08:01 ET (12:01 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATAI"],"gpt_icon":0},{"id":"2536861115","title":"Atai Life Sciences announces data from Part 2 of Phase 2a study of BPL-003","url":"https://stock-news.laohu8.com/highlight/detail?id=2536861115","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536861115?lang=en_us&edition=fundamental","pubTime":"2025-05-20 19:11","pubTimestamp":1747739477,"startTime":"0","endTime":"0","summary":"atai Life Sciences (ATAI) announced positive topline data from Part 2 of Beckley Psytech’s Phase 2a study of BPL-003, for treatment-resistant depre...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/atai-life-sciences-announces-data-from-part-2-of-phase-2a-study-of-bpl-003?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/atai-life-sciences-announces-data-from-part-2-of-phase-2a-study-of-bpl-003?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BK4539","ATAI"],"gpt_icon":0},{"id":"2536617926","title":"atai Life Sciences Announces Positive Topline Data from Part 2 of Beckley Psytech’s Phase 2a Study of BPL-003 in Combination with SSRIs for Treatment-Resistant Depression","url":"https://stock-news.laohu8.com/highlight/detail?id=2536617926","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536617926?lang=en_us&edition=fundamental","pubTime":"2025-05-20 19:00","pubTimestamp":1747738800,"startTime":"0","endTime":"0","summary":"- Positive results show that a single dose of BPL-003, administered adjunctively to SSRIs, produced a rapid and durable antidepressant effect for up to three months after dosing -BPL-003 was well-tole","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/05/20/3084684/0/en/atai-Life-Sciences-Announces-Positive-Topline-Data-from-Part-2-of-Beckley-Psytech-s-Phase-2a-Study-of-BPL-003-in-Combination-with-SSRIs-for-Treatment-Resistant-Depression.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4539","ATAI"],"gpt_icon":0},{"id":"2536615429","title":"ATAI Life Sciences: Positioned for Leadership in Scalable Psychedelic Psychiatry with Strong Financial Foundation and Promising Clinical Milestones","url":"https://stock-news.laohu8.com/highlight/detail?id=2536615429","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536615429?lang=en_us&edition=fundamental","pubTime":"2025-05-20 18:18","pubTimestamp":1747736281,"startTime":"0","endTime":"0","summary":"H.C. Wainwright analyst Patrick Trucchio has reiterated their bullish stance on ATAI stock, giving a Buy rating on May 18. Patrick Trucchio has giv...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/atai-life-sciences-positioned-for-leadership-in-scalable-psychedelic-psychiatry-with-strong-financial-foundation-and-promising-clinical-milestones?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/atai-life-sciences-positioned-for-leadership-in-scalable-psychedelic-psychiatry-with-strong-financial-foundation-and-promising-clinical-milestones?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4007","ATAI"],"gpt_icon":0},{"id":"2536302548","title":"ATAI Life Sciences: Strong Buy Rating Backed by Promising Trials and Robust Financial Health","url":"https://stock-news.laohu8.com/highlight/detail?id=2536302548","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536302548?lang=en_us&edition=fundamental","pubTime":"2025-05-19 08:15","pubTimestamp":1747613729,"startTime":"0","endTime":"0","summary":"TD Cowen analyst Ritu Baral has maintained their bullish stance on ATAI stock, giving a Buy rating on May 15. Ritu Baral has given her Buy rating d...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/atai-life-sciences-strong-buy-rating-backed-by-promising-trials-and-robust-financial-health?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/atai-life-sciences-strong-buy-rating-backed-by-promising-trials-and-robust-financial-health?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ATAI"],"gpt_icon":0},{"id":"2536553819","title":"ATAI Life Sciences: Buy Rating Backed by Promising Pipeline and Strong Cash Position Amid Upcoming Catalysts","url":"https://stock-news.laohu8.com/highlight/detail?id=2536553819","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536553819?lang=en_us&edition=fundamental","pubTime":"2025-05-18 01:46","pubTimestamp":1747503969,"startTime":"0","endTime":"0","summary":"Sumant Kulkarni, an analyst from Canaccord Genuity, maintained the Buy rating on ATAI Life Sciences (ATAI – Research Report). The associated price ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/atai-life-sciences-buy-rating-backed-by-promising-pipeline-and-strong-cash-position-amid-upcoming-catalysts?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/atai-life-sciences-buy-rating-backed-by-promising-pipeline-and-strong-cash-position-amid-upcoming-catalysts?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ATAI"],"gpt_icon":0},{"id":"2535029799","title":"Atai Life Sciences Reports First Quarter 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2535029799","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535029799?lang=en_us&edition=fundamental","pubTime":"2025-05-14 20:34","pubTimestamp":1747226071,"startTime":"0","endTime":"0","summary":"May 14 (Reuters) - :*ATAI LIFE SCIENCES REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS AND RECENT CORPORATE UPDATES  ((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))  Source Date/Time = 14-MAY-202511:00:00.803 GMT","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250514:nRSD3xbWmj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4539","ATAI"],"gpt_icon":0},{"id":"2535026033","title":"ATAI Life Sciences Q1 EPS $(0.15) Beats $(0.18) Estimate, Sales $1.55M","url":"https://stock-news.laohu8.com/highlight/detail?id=2535026033","media":"Benzinga","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535026033?lang=en_us&edition=fundamental","pubTime":"2025-05-14 20:21","pubTimestamp":1747225260,"startTime":"0","endTime":"0","summary":"ATAI Life Sciences (NASDAQ:ATAI) reported quarterly losses of $(0.15) per share which beat the analyst consensus estimate of $(0.18) by 16.67 percent. This is a 11.76 percent increase over losses of $(0.17) per share","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/05/45404379/atai-life-sciences-q1-eps-0-15-beats-0-18-estimate-sales-1-55m","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATAI"],"gpt_icon":0},{"id":"2535025510","title":"ATAI Life Sciences NV reports results for the quarter ended March 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2535025510","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535025510?lang=en_us&edition=fundamental","pubTime":"2025-05-14 19:58","pubTimestamp":1747223938,"startTime":"0","endTime":"0","summary":"ATAI Life Sciences NV reports results for the quarter ended March 31 - Earnings SummaryATAI Life Sciences NV ATAI.OQ reported a quarterly adjusted loss of 15 cents per share for the quarter ended Marc","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250514:nL8N3RM16P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATAI"],"gpt_icon":0},{"id":"2535042989","title":"ATAI Life Sciences Reports Q1 2025 Net Loss of $26.4M, Down from $26.7M in Q1 2024, as G&A Expenses Decrease","url":"https://stock-news.laohu8.com/highlight/detail?id=2535042989","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535042989?lang=en_us&edition=fundamental","pubTime":"2025-05-14 19:00","pubTimestamp":1747220419,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ATAI Life Sciences NV published the original content used to generate this news brief via GlobeNewswire  on May 14, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250514:nNDL7h0V1W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","LU2095319765.USD","ATAI","BK4588","IE00BGHQF748.EUR","NDAQ","LU2210149790.SGD","IE00B3QW5Z07.USD","IE00BKPKM429.USD","BK4539","IE00B64PRP62.GBP","BK4112","BK4585","LU2210150020.SGD"],"gpt_icon":0},{"id":"2535491042","title":"Press Release: atai Life Sciences Reports First Quarter 2025 Financial Results and Recent Corporate Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2535491042","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535491042?lang=en_us&edition=fundamental","pubTime":"2025-05-14 19:00","pubTimestamp":1747220400,"startTime":"0","endTime":"0","summary":"With clinical momentum across its pipeline, atai strengthens its position as a leader in potentially transformative psychedelic mental health treatments. -- Anticipate topline data midyear from the Phase 2b clinical trial of. BPL-003 in patients with treatment-resistant depression  - the. largest controlled trial of mebufotenin and the first and only such trial. -- Dosed the first patient in the exploratory Phase 2 study of EMP-01 (oral. R-MDMA) for the treatment of social anxiety; topline data anticipated in. -- Continued enrollment in Elumina, a Phase 2 study of VLS-01 (buccal film. DMT) in patients with TRD; topline data are anticipated in Q1'26. Cash, cash equivalents, short-term securities, and public equity holdings expected to fund operations into 2027. -- VLS-01 is an investigational proprietary oral transmucosal film. formulation of DMT applied to the buccal surface, design","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CIAS","BK4539","ATAI"],"gpt_icon":0},{"id":"2535722493","title":"Atai Life Sciences Announces First Patient Dosed In Phase 2 Study Of Emp-01 For The Treatment Of Social Anxiety Disorder","url":"https://stock-news.laohu8.com/highlight/detail?id=2535722493","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535722493?lang=en_us&edition=fundamental","pubTime":"2025-05-13 19:54","pubTimestamp":1747137259,"startTime":"0","endTime":"0","summary":"May 13 (Reuters) - :*ATAI LIFE SCIENCES ANNOUNCES FIRST PATIENT DOSED IN PHASE 2 STUDY OF EMP-01 FOR THE TREATMENT OF SOCIAL ANXIETY DISORDER*ATAI LIFE SCIENCES NV - TOPLINE DATA EXPECTED IN Q1 2026  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250513:nRSD9sfpkV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATAI","BK4007","BK4539"],"gpt_icon":0},{"id":"2534488370","title":"ATAI Life Sciences NV  expected to post a loss of 18 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2534488370","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534488370?lang=en_us&edition=fundamental","pubTime":"2025-05-09 19:29","pubTimestamp":1746790146,"startTime":"0","endTime":"0","summary":"ATAI Life Sciences NV  expected to post a loss of18cents a share - Earnings Preview ATAI Life Sciences NV ATAI.OQ, ATAI.O is expected to show no change in quarterly revenue when it reports  results on","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250509:nL8N3RH1BZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATAI"],"gpt_icon":0},{"id":"2532184007","title":"H.C. Wainwright Remains a Buy on ATAI Life Sciences (ATAI)","url":"https://stock-news.laohu8.com/highlight/detail?id=2532184007","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532184007?lang=en_us&edition=fundamental","pubTime":"2025-05-01 23:56","pubTimestamp":1746114997,"startTime":"0","endTime":"0","summary":"In a report released today, Patrick Trucchio from H.C. Wainwright reiterated a Buy rating on ATAI Life Sciences (ATAI – Research Report), with a pr...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/h-c-wainwright-remains-a-buy-on-atai-life-sciences-atai?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/h-c-wainwright-remains-a-buy-on-atai-life-sciences-atai?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BK4539","ATAI"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":57,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ATAI\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-14","symbol":"ATAI","fiscalQuarterEnding":"2025/03","expectedEps":-0.19,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1747195200000,"reportTimeType":"pre","actualEps":-0.15},{"market":"US","date":"2025-03-17","symbol":"ATAI","fiscalQuarterEnding":"2024/12","expectedEps":-0.14,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1742184000000,"reportTimeType":"pre","actualEps":-0.24},{"market":"US","date":"2024-11-13","symbol":"ATAI","fiscalQuarterEnding":"2024/09","expectedEps":-0.15,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731474000000,"reportTimeType":"pre","actualEps":-0.16},{"market":"US","date":"2024-08-13","symbol":"ATAI","fiscalQuarterEnding":"2024/06","expectedEps":-0.17,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1723521600000,"reportTimeType":"pre","actualEps":-0.36},{"market":"US","date":"2024-05-15","symbol":"ATAI","fiscalQuarterEnding":"2024/03","expectedEps":-0.2,"name":null,"time":"","type":"earning","dateTimestamp":1715745600000,"reportTimeType":"","actualEps":-0.17}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ATAI\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ATAI\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.1667,"buy":0.8333,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.8333,"analysts":6,"updateTime":1712203200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ATAI\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ATAI","date":"2025-05-29","current":-3.106176,"percent":0.510858,"low":-16.362892,"twenty":-6.884043,"median":-3.127661,"eighty":-1.95292,"high":-0.988908,"avg":-4.518494,"sd":3.432347,"marketCap":462779876},"quantilePoints":[{"date":"2021-06-18","current":-16.000917,"twenty":-14.513466,"median":-12.28229,"eighty":-12.28229,"marketCap":2967482143},{"date":"2021-06-25","current":-13.936018,"twenty":-15.793605,"median":-14.964354,"eighty":-12.943781,"marketCap":2584532005},{"date":"2021-07-02","current":-14.832727,"twenty":-15.377334,"median":-14.832727,"eighty":-14.222307,"marketCap":2750833061},{"date":"2021-07-09","current":-15.285195,"twenty":-15.443148,"median":-14.832727,"eighty":-14.447718,"marketCap":2834746438},{"date":"2021-07-16","current":-14.297992,"twenty":-15.474409,"median":-14.857407,"eighty":-14.447718,"marketCap":2651662706},{"date":"2021-07-23","current":-14.297992,"twenty":-15.410241,"median":-14.758687,"eighty":-14.219016,"marketCap":2651662706},{"date":"2021-07-30","current":-12.751374,"twenty":-15.272032,"median":-14.65174,"eighty":-13.50823,"marketCap":2364831528},{"date":"2021-08-06","current":-11.829984,"twenty":-15.199638,"median":-14.396712,"eighty":-12.935651,"marketCap":2193953378},{"date":"2021-08-13","current":-11.204756,"twenty":-15.112434,"median":-14.248632,"eighty":-12.28229,"marketCap":2078000349},{"date":"2021-08-20","current":-10.560325,"twenty":-15.04004,"median":-13.977151,"eighty":-11.857955,"marketCap":2297525475},{"date":"2021-08-27","current":-11.812763,"twenty":-14.872215,"median":-13.384829,"eighty":-11.681826,"marketCap":2570008281},{"date":"2021-09-03","current":-12.211266,"twenty":-14.827791,"median":-13.212069,"eighty":-11.659054,"marketCap":2656707356},{"date":"2021-09-10","current":-11.713137,"twenty":-14.808047,"median":-12.751374,"eighty":-11.67044,"marketCap":2548333512},{"date":"2021-09-17","current":-11.684673,"twenty":-14.758687,"median":-12.498145,"eighty":-11.521002,"marketCap":2542140721},{"date":"2021-09-24","current":-11.385795,"twenty":-14.692873,"median":-12.28229,"eighty":-11.428492,"marketCap":2477116416},{"date":"2021-10-01","current":-9.862945,"twenty":-14.65174,"median":-12.152252,"eighty":-11.204756,"marketCap":2145802095},{"date":"2021-10-08","current":-8.930733,"twenty":-14.65174,"median":-12.027425,"eighty":-11.122499,"marketCap":1942988188},{"date":"2021-10-15","current":-9.606765,"twenty":-14.470753,"median":-11.899911,"eighty":-10.837854,"marketCap":2090066976},{"date":"2021-10-22","current":-10.852086,"twenty":-14.396712,"median":-11.764171,"eighty":-10.560325,"marketCap":2361001584},{"date":"2021-10-29","current":-10.382422,"twenty":-14.297992,"median":-11.698905,"eighty":-10.432235,"marketCap":2258820531},{"date":"2021-11-05","current":-12.225498,"twenty":-14.297992,"median":-11.727369,"eighty":-10.49628,"marketCap":2659803751},{"date":"2021-11-12","current":-10.617254,"twenty":-14.199272,"median":-11.698905,"eighty":-10.49628,"marketCap":2309911057},{"date":"2021-11-19","current":-11.282109,"twenty":-13.993604,"median":-11.713137,"eighty":-10.524745,"marketCap":1867471140},{"date":"2021-11-26","current":-10.836635,"twenty":-13.980442,"median":-11.67044,"eighty":-10.52127,"marketCap":1793734082},{"date":"2021-12-03","current":-10.245898,"twenty":-13.944245,"median":-11.617248,"eighty":-10.52127,"marketCap":1695952332},{"date":"2021-12-10","current":-10.488004,"twenty":-13.50823,"median":-11.521002,"eighty":-10.494625,"marketCap":1736026820},{"date":"2021-12-17","current":-7.737687,"twenty":-13.374957,"median":-11.424934,"eighty":-10.429389,"marketCap":1280780636},{"date":"2021-12-23","current":-7.476213,"twenty":-13.358504,"median":-11.360889,"eighty":-10.36819,"marketCap":1237500189},{"date":"2021-12-31","current":-7.389055,"twenty":-13.26801,"median":-11.204756,"eighty":-10.150437,"marketCap":1223073373},{"date":"2022-01-07","current":-6.217265,"twenty":-13.004756,"median":-11.147405,"eighty":-9.828788,"marketCap":1029112851},{"date":"2022-01-14","current":-5.771792,"twenty":-12.797443,"median":-11.108267,"eighty":-9.539873,"marketCap":955375793},{"date":"2022-01-21","current":-5.093897,"twenty":-12.728889,"median":-11.044222,"eighty":-9.23815,"marketCap":843167227},{"date":"2022-01-28","current":-4.784002,"twenty":-12.689469,"median":-10.952279,"eighty":-8.879497,"marketCap":791871882},{"date":"2022-02-04","current":-4.968002,"twenty":-12.675237,"median":-10.904425,"eighty":-7.737687,"marketCap":822328493},{"date":"2022-02-11","current":-5.365055,"twenty":-12.577704,"median":-10.837245,"eighty":-7.400676,"marketCap":888050654},{"date":"2022-02-18","current":-5.60716,"twenty":-12.392673,"median":-10.817267,"eighty":-7.106276,"marketCap":928125142},{"date":"2022-02-25","current":-5.35537,"twenty":-12.308745,"median":-10.795157,"eighty":-6.542655,"marketCap":886447674},{"date":"2022-03-04","current":-4.958318,"twenty":-12.28229,"median":-10.657477,"eighty":-6.221139,"marketCap":820725514},{"date":"2022-03-11","current":-5.05516,"twenty":-12.280894,"median":-10.617254,"eighty":-5.82215,"marketCap":836755309},{"date":"2022-03-18","current":-5.471581,"twenty":-12.275311,"median":-10.563883,"eighty":-5.583918,"marketCap":905683428},{"date":"2022-03-25","current":-4.909896,"twenty":-12.265348,"median":-10.524745,"eighty":-5.483202,"marketCap":812710616},{"date":"2022-04-01","current":-5.094954,"twenty":-12.222652,"median":-10.492142,"eighty":-5.388297,"marketCap":854973992},{"date":"2022-04-08","current":-4.740605,"twenty":-12.188494,"median":-10.432235,"eighty":-5.366992,"marketCap":795511515},{"date":"2022-04-14","current":-5.094954,"twenty":-12.097408,"median":-10.382422,"eighty":-5.306949,"marketCap":854973992},{"date":"2022-04-22","current":-4.577797,"twenty":-12.093238,"median":-10.307044,"eighty":-5.219791,"marketCap":768190917},{"date":"2022-04-29","current":-4.109123,"twenty":-12.076059,"median":-10.190287,"eighty":-5.114108,"marketCap":689543647},{"date":"2022-05-06","current":-3.697253,"twenty":-12.027425,"median":-10.00171,"eighty":-5.093897,"marketCap":620428550},{"date":"2022-05-13","current":-3.486528,"twenty":-11.976434,"median":-9.777552,"eighty":-5.05516,"marketCap":585067337},{"date":"2022-05-20","current":-3.130675,"twenty":-11.969838,"median":-9.603207,"eighty":-4.977686,"marketCap":642931140},{"date":"2022-05-27","current":-3.185462,"twenty":-11.892215,"median":-9.371933,"eighty":-4.958318,"marketCap":654182434},{"date":"2022-06-03","current":-2.888048,"twenty":-11.885582,"median":-9.22961,"eighty":-4.898937,"marketCap":593103976},{"date":"2022-06-10","current":-2.57498,"twenty":-11.840772,"median":-8.941408,"eighty":-4.879612,"marketCap":528810862},{"date":"2022-06-17","current":-2.543674,"twenty":-11.81779,"median":-8.076634,"eighty":-4.813054,"marketCap":522381551},{"date":"2022-06-24","current":-2.966315,"twenty":-11.813554,"median":-7.737687,"eighty":-4.774305,"marketCap":609177255},{"date":"2022-07-01","current":-2.856741,"twenty":-11.783608,"median":-7.529477,"eighty":-4.711874,"marketCap":586674665},{"date":"2022-07-08","current":-3.373303,"twenty":-11.74945,"median":-7.403581,"eighty":-4.629513,"marketCap":692758303},{"date":"2022-07-15","current":-3.326343,"twenty":-11.721676,"median":-7.253476,"eighty":-4.405411,"marketCap":683114336},{"date":"2022-07-22","current":-3.044582,"twenty":-11.701751,"median":-7.050108,"eighty":-4.202991,"marketCap":625250533},{"date":"2022-07-29","current":-3.021102,"twenty":-11.67898,"median":-6.52716,"eighty":-3.570818,"marketCap":620428550},{"date":"2022-08-05","current":-3.428089,"twenty":-11.664747,"median":-6.314108,"eighty":-3.385825,"marketCap":704009598},{"date":"2022-08-12","current":-3.584623,"twenty":-11.647669,"median":-6.178529,"eighty":-3.414001,"marketCap":736156155},{"date":"2022-08-19","current":-3.779551,"twenty":-11.620771,"median":-5.897686,"eighty":-3.437481,"marketCap":731426327},{"date":"2022-08-26","current":-3.913341,"twenty":-11.593801,"median":-5.616844,"eighty":-3.45157,"marketCap":757317525},{"date":"2022-09-02","current":-3.645762,"twenty":-11.559429,"median":-5.573265,"eighty":-3.457831,"marketCap":705535130},{"date":"2022-09-09","current":-3.6374,"twenty":-11.512049,"median":-5.544213,"eighty":-3.467223,"marketCap":703916930},{"date":"2022-09-16","current":-3.22767,"twenty":-11.466687,"median":-5.471581,"eighty":-3.45157,"marketCap":624625138},{"date":"2022-09-23","current":-2.759988,"twenty":-11.427069,"median":-5.394107,"eighty":-3.350449,"marketCap":534118488},{"date":"2022-09-30","current":-2.837131,"twenty":-11.41426,"median":-5.374739,"eighty":-3.307558,"marketCap":549047266},{"date":"2022-10-07","current":-2.888559,"twenty":-11.375833,"median":-5.360212,"eighty":-3.252772,"marketCap":558999784},{"date":"2022-10-14","current":-2.579989,"twenty":-11.325208,"median":-5.306949,"eighty":-3.218334,"marketCap":499284674},{"date":"2022-10-21","current":-2.451418,"twenty":-11.266638,"median":-5.248844,"eighty":-3.163869,"marketCap":474403378},{"date":"2022-10-28","current":-2.571418,"twenty":-11.198267,"median":-5.190739,"eighty":-3.130675,"marketCap":497625921},{"date":"2022-11-04","current":-2.579989,"twenty":-11.169465,"median":-5.133055,"eighty":-3.10835,"marketCap":499284674},{"date":"2022-11-11","current":-2.324356,"twenty":-11.153809,"median":-5.094954,"eighty":-3.046147,"marketCap":456157094},{"date":"2022-11-18","current":-2.594826,"twenty":-11.133885,"median":-5.089637,"eighty":-3.008579,"marketCap":509237192},{"date":"2022-11-25","current":-2.61173,"twenty":-11.122499,"median":-5.05516,"eighty":-2.966315,"marketCap":512554698},{"date":"2022-12-02","current":-3.000532,"twenty":-11.108267,"median":-5.035791,"eighty":-2.958488,"marketCap":588857339},{"date":"2022-12-09","current":-2.704705,"twenty":-11.051338,"median":-4.977686,"eighty":-2.927181,"marketCap":530800982},{"date":"2022-12-16","current":-2.61173,"twenty":-11.044222,"median":-4.970453,"eighty":-2.897131,"marketCap":512554698},{"date":"2022-12-23","current":-2.256738,"twenty":-11.020636,"median":-4.934107,"eighty":-2.888559,"marketCap":442887069},{"date":"2022-12-30","current":-2.248286,"twenty":-10.966404,"median":-4.905054,"eighty":-2.87709,"marketCap":441228316},{"date":"2023-01-06","current":-1.538301,"twenty":-10.952166,"median":-4.892183,"eighty":-2.856741,"marketCap":301893058},{"date":"2023-01-13","current":-1.521396,"twenty":-10.943173,"median":-4.880844,"eighty":-2.85213,"marketCap":298575552},{"date":"2023-01-20","current":-1.605918,"twenty":-10.924258,"median":-4.874683,"eighty":-2.840559,"marketCap":315163083},{"date":"2023-01-27","current":-1.512944,"twenty":-10.883489,"median":-4.813054,"eighty":-2.800636,"marketCap":296916799},{"date":"2023-02-03","current":-1.580562,"twenty":-10.846393,"median":-4.784002,"eighty":-2.749703,"marketCap":310186824},{"date":"2023-02-10","current":-1.479135,"twenty":-10.837366,"median":-4.733251,"eighty":-2.691417,"marketCap":290281787},{"date":"2023-02-17","current":-1.597466,"twenty":-10.832761,"median":-4.711874,"eighty":-2.670896,"marketCap":313504330},{"date":"2023-02-24","current":-1.369257,"twenty":-10.825014,"median":-4.66399,"eighty":-2.64229,"marketCap":268717997},{"date":"2023-03-03","current":-1.318543,"twenty":-10.815691,"median":-4.545321,"eighty":-2.613421,"marketCap":258765478},{"date":"2023-03-10","current":-1.124143,"twenty":-10.806543,"median":-4.405411,"eighty":-2.591472,"marketCap":220614158},{"date":"2023-03-17","current":-1.031169,"twenty":-10.793768,"median":-4.223755,"eighty":-2.579989,"marketCap":202367874},{"date":"2023-03-24","current":-1.361769,"twenty":-10.764972,"median":-4.109123,"eighty":-2.564171,"marketCap":207513095},{"date":"2023-03-31","current":-1.971841,"twenty":-10.666193,"median":-3.984416,"eighty":-2.543762,"marketCap":300478961},{"date":"2023-04-06","current":-1.830217,"twenty":-10.642951,"median":-3.913341,"eighty":-2.519989,"marketCap":278897599},{"date":"2023-04-14","current":-2.17883,"twenty":-10.633267,"median":-3.86317,"eighty":-2.477133,"marketCap":332020952},{"date":"2023-04-21","current":-2.385818,"twenty":-10.617254,"median":-3.783732,"eighty":-2.434234,"marketCap":363562942},{"date":"2023-04-28","current":-2.037206,"twenty":-10.575162,"median":-3.697253,"eighty":-2.425704,"marketCap":310439590},{"date":"2023-05-05","current":-2.124359,"twenty":-10.567441,"median":-3.666869,"eighty":-2.385818,"marketCap":323720428},{"date":"2023-05-12","current":-2.135253,"twenty":-10.560325,"median":-3.6374,"eighty":-2.331419,"marketCap":325380532},{"date":"2023-05-19","current":-2.077211,"twenty":-10.524745,"median":-3.587229,"eighty":-2.254276,"marketCap":308779485},{"date":"2023-05-26","current":-1.976701,"twenty":-10.524745,"median":-3.584623,"eighty":-2.2333,"marketCap":293838542},{"date":"2023-06-02","current":-1.920862,"twenty":-10.510847,"median":-3.520334,"eighty":-2.189724,"marketCap":285538018},{"date":"2023-06-09","current":-1.999036,"twenty":-10.498498,"median":-3.467223,"eighty":-2.177507,"marketCap":297158752},{"date":"2023-06-16","current":-1.999036,"twenty":-10.491314,"median":-3.456685,"eighty":-2.152683,"marketCap":297158752},{"date":"2023-06-23","current":-1.731009,"twenty":-10.476383,"median":-3.43983,"eighty":-2.128717,"marketCap":257316237},{"date":"2023-06-30","current":-1.820352,"twenty":-10.453608,"median":-3.388956,"eighty":-2.121882,"marketCap":270597075},{"date":"2023-07-07","current":-2.121882,"twenty":-10.432235,"median":-3.343366,"eighty":-2.121882,"marketCap":315419904},{"date":"2023-07-14","current":-2.278231,"twenty":-10.418003,"median":-3.326343,"eighty":-2.121882,"marketCap":338661371},{"date":"2023-07-21","current":-2.311735,"twenty":-10.382422,"median":-3.283295,"eighty":-2.121882,"marketCap":343641685},{"date":"2023-07-28","current":-2.278231,"twenty":-10.36819,"median":-3.248076,"eighty":-2.121882,"marketCap":338661371},{"date":"2023-08-04","current":-2.155386,"twenty":-10.36819,"median":-3.226133,"eighty":-2.124359,"marketCap":320400218},{"date":"2023-08-11","current":-1.909694,"twenty":-10.245898,"median":-3.199177,"eighty":-2.121882,"marketCap":283877913},{"date":"2023-08-18","current":-1.819437,"twenty":-10.245898,"median":-3.166698,"eighty":-2.099547,"marketCap":263956656},{"date":"2023-08-25","current":-1.785108,"twenty":-10.190287,"median":-3.145701,"eighty":-2.077211,"marketCap":258976342},{"date":"2023-09-01","current":-1.750779,"twenty":-10.090661,"median":-3.122848,"eighty":-2.0481,"marketCap":253996028},{"date":"2023-09-08","current":-1.659235,"twenty":-10.056503,"median":-3.113997,"eighty":-2.036273,"marketCap":240715190},{"date":"2023-09-15","current":-1.659235,"twenty":-9.973957,"median":-3.068062,"eighty":-2.021372,"marketCap":240715190},{"date":"2023-09-22","current":-1.499033,"twenty":-9.881447,"median":-3.048495,"eighty":-1.999036,"marketCap":217473723},{"date":"2023-09-29","current":-1.48759,"twenty":-9.794631,"median":-3.028928,"eighty":-1.986842,"marketCap":215813618},{"date":"2023-10-06","current":-1.739336,"twenty":-9.718376,"median":-3.00299,"eighty":-1.975729,"marketCap":252335923},{"date":"2023-10-13","current":-1.430375,"twenty":-9.626128,"median":-2.989795,"eighty":-1.963299,"marketCap":207513095},{"date":"2023-10-20","current":-1.476147,"twenty":-9.601072,"median":-2.966009,"eighty":-1.935811,"marketCap":214153514},{"date":"2023-10-27","current":-1.304502,"twenty":-9.569761,"median":-2.962095,"eighty":-1.921174,"marketCap":189251942},{"date":"2023-11-03","current":-1.418932,"twenty":-9.434555,"median":-2.948559,"eighty":-1.901569,"marketCap":205852990},{"date":"2023-11-10","current":-1.350274,"twenty":-9.347738,"median":-2.925013,"eighty":-1.841353,"marketCap":195892361},{"date":"2023-11-17","current":-2.752665,"twenty":-9.246689,"median":-2.922845,"eighty":-1.841353,"marketCap":184271628},{"date":"2023-11-24","current":-2.727866,"twenty":-9.22961,"median":-2.905702,"eighty":-1.842323,"marketCap":182611523},{"date":"2023-12-01","current":-2.579073,"twenty":-9.080172,"median":-2.896503,"eighty":-1.865209,"marketCap":172650895},{"date":"2023-12-08","current":-2.901457,"twenty":-8.952082,"median":-2.895875,"eighty":-1.865209,"marketCap":194232256},{"date":"2023-12-15","current":-3.174244,"twenty":-8.930733,"median":-2.895875,"eighty":-1.899538,"marketCap":212493409},{"date":"2023-12-22","current":-3.223841,"twenty":-8.84534,"median":-2.897131,"eighty":-1.909694,"marketCap":215813618},{"date":"2023-12-29","current":-3.695018,"twenty":-8.384116,"median":-2.90358,"eighty":-1.910466,"marketCap":247355609},{"date":"2024-01-05","current":-4.26539,"twenty":-8.016592,"median":-2.914274,"eighty":-1.912259,"marketCap":285538018},{"date":"2024-01-12","current":-4.959756,"twenty":-7.768677,"median":-2.934273,"eighty":-1.918068,"marketCap":332020952},{"date":"2024-01-19","current":-4.389384,"twenty":-7.737687,"median":-2.94961,"eighty":-1.920862,"marketCap":293838542},{"date":"2024-01-26","current":-4.314988,"twenty":-7.737687,"median":-2.965702,"eighty":-1.922424,"marketCap":288858228},{"date":"2024-02-02","current":-4.488579,"twenty":-7.58274,"median":-2.979741,"eighty":-1.939158,"marketCap":300478961},{"date":"2024-02-09","current":-4.339787,"twenty":-7.476213,"median":-2.998031,"eighty":-1.939158,"marketCap":290518333},{"date":"2024-02-16","current":-4.46378,"twenty":-7.418108,"median":-3.000652,"eighty":-1.954365,"marketCap":298818856},{"date":"2024-02-23","current":-4.538177,"twenty":-7.394866,"median":-3.013275,"eighty":-1.954365,"marketCap":303799171},{"date":"2024-03-01","current":-4.810963,"twenty":-7.350318,"median":-3.044582,"eighty":-1.963299,"marketCap":322060323},{"date":"2024-03-08","current":-5.430933,"twenty":-7.270908,"median":-3.060235,"eighty":-1.965533,"marketCap":363562942},{"date":"2024-03-15","current":-4.166195,"twenty":-7.145013,"median":-3.107195,"eighty":-1.970579,"marketCap":278897599},{"date":"2024-03-22","current":-4.141396,"twenty":-7.102403,"median":-3.113997,"eighty":-1.971841,"marketCap":277237494},{"date":"2024-03-28","current":-4.438982,"twenty":-7.040424,"median":-3.119834,"eighty":-1.974757,"marketCap":297158752},{"date":"2024-04-05","current":-10.36014,"twenty":-7.360002,"median":-3.130675,"eighty":-1.976701,"marketCap":416726253},{"date":"2024-04-12","current":-10.195038,"twenty":-7.620244,"median":-3.158068,"eighty":-1.976701,"marketCap":410085198},{"date":"2024-04-19","current":-7.883612,"twenty":-7.753182,"median":-3.174244,"eighty":-1.980321,"marketCap":317110416},{"date":"2024-04-26","current":-7.658097,"twenty":-7.782413,"median":-3.207973,"eighty":-1.985815,"marketCap":308039288},{"date":"2024-05-03","current":-8.86508,"twenty":-8.098174,"median":-3.224596,"eighty":-1.994569,"marketCap":356588959},{"date":"2024-05-10","current":-8.532119,"twenty":-8.215806,"median":-3.247573,"eighty":-1.999036,"marketCap":343195946},{"date":"2024-05-17","current":-9.212104,"twenty":-8.290722,"median":-3.273439,"eighty":-1.999036,"marketCap":311387542},{"date":"2024-05-24","current":-8.072973,"twenty":-8.40706,"median":-3.295036,"eighty":-1.999036,"marketCap":272882630},{"date":"2024-05-31","current":-8.32061,"twenty":-8.347627,"median":-3.327178,"eighty":-2.004071,"marketCap":281253263},{"date":"2024-06-07","current":-7.329773,"twenty":-8.32061,"median":-3.344736,"eighty":-2.015005,"marketCap":247760983},{"date":"2024-06-14","current":-6.636416,"twenty":-8.310705,"median":-3.372634,"eighty":-2.020335,"marketCap":224324133},{"date":"2024-06-21","current":-6.586891,"twenty":-8.271083,"median":-3.404609,"eighty":-2.021372,"marketCap":222650073},{"date":"2024-06-28","current":-6.537365,"twenty":-8.258961,"median":-3.428089,"eighty":-2.021372,"marketCap":220976012},{"date":"2024-07-05","current":-6.339263,"twenty":-8.236933,"median":-3.45157,"eighty":-2.02236,"marketCap":214279769},{"date":"2024-07-12","current":-7.230722,"twenty":-8.217076,"median":-3.467223,"eighty":-2.027558,"marketCap":244412862},{"date":"2024-07-15","current":-7.626926,"twenty":-8.212596,"median":-3.467223,"eighty":-2.028803,"marketCap":257805347},{"date":"2024-08-02","current":-7.03262,"twenty":-8.208117,"median":-3.469526,"eighty":-2.030049,"marketCap":237716619},{"date":"2024-08-09","current":-6.48784,"twenty":-8.199158,"median":-3.496628,"eighty":-2.03254,"marketCap":219301951},{"date":"2024-08-16","current":-3.603478,"twenty":-8.183187,"median":-3.518664,"eighty":-2.03534,"marketCap":209257587},{"date":"2024-08-23","current":-3.727517,"twenty":-8.147307,"median":-3.578867,"eighty":-2.037206,"marketCap":216460651},{"date":"2024-08-30","current":-3.756413,"twenty":-8.098174,"median":-3.587229,"eighty":-2.041107,"marketCap":218138641},{"date":"2024-09-06","current":-3.525249,"twenty":-8.0757,"median":-3.585926,"eighty":-2.045465,"marketCap":204714725},{"date":"2024-09-13","current":-3.554144,"twenty":-8.073768,"median":-3.584623,"eighty":-2.052458,"marketCap":206392714},{"date":"2024-09-20","current":-3.640831,"twenty":-8.072973,"median":-3.587229,"eighty":-2.063352,"marketCap":211426683},{"date":"2024-09-27","current":-3.438562,"twenty":-8.056855,"median":-3.58304,"eighty":-2.069888,"marketCap":199680756},{"date":"2024-10-04","current":-3.062921,"twenty":-8.009174,"median":-3.566505,"eighty":-2.072817,"marketCap":177866892},{"date":"2024-10-11","current":-3.120712,"twenty":-7.973918,"median":-3.525249,"eighty":-2.078639,"marketCap":181222871},{"date":"2024-10-18","current":-3.467458,"twenty":-7.964126,"median":-3.525249,"eighty":-2.083821,"marketCap":201358746},{"date":"2024-10-25","current":-3.294085,"twenty":-7.923108,"median":-3.525249,"eighty":-2.092846,"marketCap":191290808},{"date":"2024-10-31","current":-3.236294,"twenty":-7.880129,"median":-3.520334,"eighty":-2.099547,"marketCap":187934829},{"date":"2024-11-08","current":-3.90089,"twenty":-7.849549,"median":-3.506811,"eighty":-2.10178,"marketCap":226528589},{"date":"2024-11-15","current":-1.787552,"twenty":-7.782776,"median":-3.516995,"eighty":-2.099547,"marketCap":229884568},{"date":"2024-11-22","current":-1.98327,"twenty":-7.780925,"median":-3.496353,"eighty":-2.090613,"marketCap":255054411},{"date":"2024-11-29","current":-2.322561,"twenty":-7.776424,"median":-3.479178,"eighty":-2.099547,"marketCap":298688264},{"date":"2024-12-06","current":-1.944166,"twenty":-7.775808,"median":-3.467458,"eighty":-2.088379,"marketCap":250025570},{"date":"2024-12-13","current":-1.813685,"twenty":-7.737687,"median":-3.467223,"eighty":-2.074647,"marketCap":233245330},{"date":"2024-12-20","current":-1.552723,"twenty":-7.737687,"median":-3.45157,"eighty":-2.058994,"marketCap":199684851},{"date":"2024-12-27","current":-1.631012,"twenty":-7.721753,"median":-3.438562,"eighty":-2.037206,"marketCap":209752995},{"date":"2025-01-03","current":-2.087695,"twenty":-7.706399,"median":-3.428089,"eighty":-2.034318,"marketCap":268483833},{"date":"2025-01-10","current":-2.113791,"twenty":-7.689891,"median":-3.409667,"eighty":-2.036184,"marketCap":271839881},{"date":"2025-01-17","current":-1.813685,"twenty":-7.669138,"median":-3.39269,"eighty":-2.023348,"marketCap":233245330},{"date":"2025-01-24","current":-1.970262,"twenty":-7.651863,"median":-3.37308,"eighty":-2.013314,"marketCap":253381617},{"date":"2025-01-31","current":-2.087695,"twenty":-7.626926,"median":-3.351876,"eighty":-1.999036,"marketCap":268483833},{"date":"2025-02-07","current":-2.766196,"twenty":-7.618089,"median":-3.346286,"eighty":-2.001554,"marketCap":355741079},{"date":"2025-02-14","current":-2.961917,"twenty":-7.561435,"median":-3.328012,"eighty":-2.013314,"marketCap":380911438},{"date":"2025-02-21","current":-2.661811,"twenty":-7.476213,"median":-3.326343,"eighty":-2.020076,"marketCap":342316887},{"date":"2025-02-28","current":-2.152935,"twenty":-7.418108,"median":-3.294085,"eighty":-2.021372,"marketCap":276873953},{"date":"2025-03-07","current":-2.048551,"twenty":-7.389055,"median":-3.287209,"eighty":-2.021372,"marketCap":263449761},{"date":"2025-03-14","current":-1.813685,"twenty":-7.340634,"median":-3.272498,"eighty":-1.999036,"marketCap":233245330},{"date":"2025-03-21","current":-1.820069,"twenty":-7.329773,"median":-3.248076,"eighty":-1.987869,"marketCap":271679843},{"date":"2025-03-28","current":-2.085772,"twenty":-7.253476,"median":-3.236294,"eighty":-1.98331,"marketCap":311341134},{"date":"2025-04-04","current":-1.747,"twenty":-7.230722,"median":-3.22767,"eighty":-1.976701,"marketCap":260772988},{"date":"2025-04-11","current":-1.607506,"twenty":-7.117897,"median":-3.220305,"eighty":-1.970262,"marketCap":239950810},{"date":"2025-04-17","current":-1.886495,"twenty":-7.102403,"median":-3.19798,"eighty":-1.965533,"marketCap":281595166},{"date":"2025-04-25","current":-2.032632,"twenty":-7.045802,"median":-3.178503,"eighty":-1.957214,"marketCap":303408876},{"date":"2025-05-02","current":-1.95292,"twenty":-7.007874,"median":-3.172829,"eighty":-1.956644,"marketCap":291510488},{"date":"2025-05-09","current":-1.873886,"twenty":-6.986813,"median":-3.154155,"eighty":-1.954076,"marketCap":279713042},{"date":"2025-05-16","current":-2.185868,"twenty":-6.943474,"median":-3.149608,"eighty":-1.95292,"marketCap":325665898},{"date":"2025-05-23","current":-2.708867,"twenty":-6.893948,"median":-3.130675,"eighty":-1.95292,"marketCap":403585960},{"date":"2025-05-29","current":-3.106176,"twenty":-6.884043,"median":-3.127661,"eighty":-1.95292,"marketCap":462779876}],"updateTime":1748648232783}}}